{"DataElement":{"publicId":"4616452","version":"1","preferredName":"Children's Oncology Group Neuroblastoma Risk Group Assignment Category","preferredDefinition":"Text term that represents the categorization of patients on the basis of prognostic factors per a system developed by Children's Oncology Group (COG). Risk level is used to assign treatment intensity.","longName":"3521411v1.0:4616451v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3521411","version":"1","preferredName":"Neuroblastoma Children's Oncology Group Risk Assessment","preferredDefinition":"A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation._An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers._The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.","longName":"2961432v1.0:3521409v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2961432","version":"1","preferredName":"Neuroblastoma","preferredDefinition":"Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)","longName":"C3270","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"78A9872E-E000-5A53-E040-BB89AD437199","latestVersionIndicator":"Yes","beginDate":"2009-11-18","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-18","modifiedBy":"ONEDATA","dateModified":"2009-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3521409","version":"1","preferredName":"Children's Oncology Group Risk Assessment","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.:The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.","longName":"C39353:C15367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Health Risk Assessment","conceptCode":"C15367","definition":"An estimated probability that one or more adverse event(s) will occur as a result of exposure to an actual or potential hazardous situation or chemical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BCA8-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"ONEDATA","dateModified":"2012-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BCB9-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Reviewed and approved for release by T.Davidsen. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4616451","version":"1","preferredName":"COG Risk Assement Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"4616451v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E543E-3A87-D32B-E050-BB89AD432BF4","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"Low Risk","valueDescription":"Low Risk","ValueMeaning":{"publicId":"2957593","version":"1","preferredName":"Low Risk","longName":"2957593","preferredDefinition":"A minimum level or position or degree; less than normal in degree or intensity or amount.: Risk is the potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable. (from WIkipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low","conceptCode":"C54722","definition":"A minimum level or position or degree; less than normal in degree, intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7731E68C-E025-7118-E040-BB89AD43735A","latestVersionIndicator":"Yes","beginDate":"2009-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E543E-3A91-D32B-E050-BB89AD432BF4","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"Intermediate Risk","valueDescription":"Intermediate Risk","ValueMeaning":{"publicId":"3521415","version":"1","preferredName":"Intermediate Risk","longName":"3521415","preferredDefinition":"Lying between two extremes in time or space or degree.: Risk is the potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable. (from WIkipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate","conceptCode":"C73705","definition":"Lying between two extremes in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BD29-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E543E-3AA5-D32B-E050-BB89AD432BF4","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"High Risk","valueDescription":"High Risk","ValueMeaning":{"publicId":"3521414","version":"1","preferredName":"High Risk","longName":"3521414","preferredDefinition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.: Risk is the potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable. (from WIkipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High","conceptCode":"C25227","definition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BD03-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E543E-3AB9-D32B-E050-BB89AD432BF4","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"642BDBB1-BDEF-5061-E053-F662850A5184","beginDate":"2018-02-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-01","modifiedBy":"ONEDATA","dateModified":"2018-02-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"092E543E-3A71-D32B-E050-BB89AD432BF4","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"COOPERM","dateModified":"2018-02-01","changeDescription":"Changed coded values to text term as part of TARGET harmonization project per request by T.Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]},{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650574","version":"1","longName":"NBL","context":"OCG"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5806867","version":"1","longName":"Neuroblastoma","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"neuroblastoma_COG_risk_assessments","type":"HCMI Name","context":"OCG"},{"name":"GDC","type":"USED_BY","context":"GDC"},{"name":"cog_neuroblastoma_risk_group","type":"GDC_Name","context":"GDC"}],"ReferenceDocuments":[{"name":"COG Risk Group","type":"Preferred Question Text","description":"COG Risk Group","url":null,"context":"NCIP"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"COG risk classification","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"092E543E-3B23-D32B-E050-BB89AD432BF4","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"COOPERM","dateModified":"2018-02-01","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}